| Symbol |
Name |
|
AAAS
|
achalasia, adrenocortical insufficiency, alacrimia
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1
|
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACADVL
|
acyl-CoA dehydrogenase, very long chain
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM8
|
ADAM metallopeptidase domain 8
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS14
|
ADAM metallopeptidase with thrombospondin type 1 motif, 14
|
|
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM2
|
apoptosis-inducing factor, mitochondrion-associated, 2
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKR1D1
|
aldo-keto reductase family 1, member D1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALMS1
|
Alstrom syndrome protein 1
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALS2
|
amyotrophic lateral sclerosis 2 (juvenile)
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMH
|
anti-Mullerian hormone
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANO5
|
anoctamin 5
|
|
ANXA5
|
annexin A5
|
|
AP4B1
|
adaptor-related protein complex 4, beta 1 subunit
|
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLN
|
apelin
|
|
APLNR
|
apelin receptor
|
|
APOA1
|
apolipoprotein A-I
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC1
|
apolipoprotein C-I
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
APOO
|
apolipoprotein O
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APTX
|
aprataxin
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARHGAP36
|
Rho GTPase activating protein 36
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARRB2
|
arrestin, beta 2
|
|
ARX
|
aristaless related homeobox
|
|
ASH2L
|
ash2 (absent, small, or homeotic)-like (Drosophila)
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATG5
|
autophagy related 5
|
|
ATG7
|
autophagy related 7
|
|
ATL1
|
atlastin GTPase 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATN1
|
atrophin 1
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATP6V0A4
|
ATPase, H+ transporting, lysosomal V0 subunit a4
|
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATXN2
|
ataxin 2
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
AXIN1
|
axin 1
|
|
AXIN2
|
axin 2
|
|
B2M
|
beta-2-microglobulin
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAX
|
BCL2-associated X protein
|
|
BCCIP
|
BRCA2 and CDKN1A interacting protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST1
|
bestrophin 1
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIN1
|
bridging integrator 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLNK
|
B-cell linker
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRINP3
|
bone morphogenetic protein/retinoic acid inducible neural-specific 3
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
C10ORF2
|
chromosome 10 open reading frame 2
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QC
|
complement component 1, q subcomponent, C chain
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA2D4
|
calcium channel, voltage-dependent, alpha 2/delta subunit 4
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALHM1
|
calcium homeostasis modulator 1
|
|
CAPN10
|
calpain 10
|
|
CAPN3
|
calpain 3, (p94)
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAST
|
calpastatin
|
|
CBR1
|
carbonyl reductase 1
|
|
CBS
|
cystathionine-beta-synthase
|
|
CC2D1A
|
coiled-coil and C2 domain containing 1A
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CD34
|
CD34 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD47
|
CD47 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CDC6
|
cell division cycle 6
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDK5RAP3
|
CDK5 regulatory subunit associated protein 3
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFI
|
complement factor I
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHGB
|
chromogranin B
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CIZ1
|
CDKN1A interacting zinc finger protein 1
|
|
CKB
|
creatine kinase, brain
|
|
CKM
|
creatine kinase, muscle
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLCN5
|
chloride channel, voltage-sensitive 5
|
|
CLDN16
|
claudin 16
|
|
CLN5
|
ceroid-lipofuscinosis, neuronal 5
|
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
|
|
CLOCK
|
clock circadian regulator
|
|
CLSPN
|
claspin
|
|
CLU
|
clusterin
|
|
CMA1
|
chymase 1, mast cell
|
|
CNBP
|
CCHC-type zinc finger, nucleic acid binding protein
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNTF
|
ciliary neurotrophic factor
|
|
CNTFR
|
ciliary neurotrophic factor receptor
|
|
COCH
|
cochlin
|
|
COL15A1
|
collagen, type XV, alpha 1
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL25A1
|
collagen, type XXV, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COMMD1
|
copper metabolism (Murr1) domain containing 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPT2
|
carnitine palmitoyltransferase 2
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRB1
|
crumbs family member 1, photoreceptor morphogenesis associated
|
|
CREM
|
cAMP responsive element modulator
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRX
|
cone-rod homeobox
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CST3
|
cystatin C
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CUBN
|
cubilin (intrinsic factor-cobalamin receptor)
|
|
CUL5
|
cullin 5
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL3
|
chemokine (C-X-C motif) ligand 3
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP4F22
|
cytochrome P450, family 4, subfamily F, polypeptide 22
|
|
DAB2IP
|
DAB2 interacting protein
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DAOA-AS1
|
DAOA antisense RNA 1
|
|
DARS2
|
aspartyl-tRNA synthetase 2, mitochondrial
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DCHS2
|
dachsous cadherin-related 2
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DFNY1
|
deafness, Y-linked 1
|
|
DHFR
|
dihydrofolate reductase
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIRC2
|
disrupted in renal carcinoma 2
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK4
|
dickkopf WNT signaling pathway inhibitor 4
|
|
DLGAP3
|
discs, large (Drosophila) homolog-associated protein 3
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNAJC19
|
DnaJ (Hsp40) homolog, subfamily C, member 19
|
|
DNAJC2
|
DnaJ (Hsp40) homolog, subfamily C, member 2
|
|
DNM2
|
dynamin 2
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DOK7
|
docking protein 7
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DRD5
|
dopamine receptor D5
|
|
DSG1
|
desmoglein 1
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DVL1
|
dishevelled segment polarity protein 1
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
DYSF
|
dysferlin
|
|
EDA2R
|
ectodysplasin A2 receptor
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4
|
|
ELN
|
elastin
|
|
ELOVL5
|
ELOVL fatty acid elongase 5
|
|
ENG
|
endoglin
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EOMES
|
eomesodermin
|
|
EP400
|
E1A binding protein p400
|
|
EPHB2
|
EPH receptor B2
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETHE1
|
ethylmalonic encephalopathy 1
|
|
ETV6
|
ets variant 6
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
FA2H
|
fatty acid 2-hydroxylase
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3
|
|
FERMT1
|
fermitin family member 1
|
|
FGB
|
fibrinogen beta chain
|
|
FGD4
|
FYVE, RhoGEF and PH domain containing 4
|
|
FGF14
|
fibroblast growth factor 14
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FH
|
fumarate hydratase
|
|
FHIT
|
fragile histidine triad
|
|
FIZ1
|
FLT3-interacting zinc finger 1
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLCN
|
folliculin
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FN3K
|
fructosamine 3 kinase
|
|
FOXC2
|
forkhead box C2
|
|
FOXM1
|
forkhead box M1
|
|
FOXO4
|
forkhead box O4
|
|
FOXP3
|
forkhead box P3
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTO
|
fat mass and obesity associated
|
|
FUS
|
FUS RNA binding protein
|
|
FXN
|
frataxin
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GAA
|
glucosidase, alpha; acid
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GABRA6
|
gamma-aminobutyric acid (GABA) A receptor, alpha 6
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALC
|
galactosylceramidase
|
|
GALR1
|
galanin receptor 1
|
|
GATA4
|
GATA binding protein 4
|
|
GBA
|
glucosidase, beta, acid
|
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF15
|
growth differentiation factor 15
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLUD2
|
glutamate dehydrogenase 2
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRN
|
granulin
|
|
GRXCR2
|
glutaredoxin, cysteine rich 2
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GSTZ1
|
glutathione S-transferase zeta 1
|
|
H2AFZ
|
H2A histone family, member Z
|
|
HAP1
|
huntingtin-associated protein 1
|
|
HBE1
|
hemoglobin, epsilon 1
|
|
HECTD2
|
HECT domain containing E3 ubiquitin protein ligase 2
|
|
HELB
|
helicase (DNA) B
|
|
HEXA
|
hexosaminidase A (alpha polypeptide)
|
|
HFE
|
hemochromatosis
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HMGB3
|
high mobility group box 3
|
|
HMGCL
|
3-hydroxymethyl-3-methylglutaryl-CoA lyase
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
|
|
HP
|
haptoglobin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTATIP2
|
HIV-1 Tat interactive protein 2, 30kDa
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTRA4
|
HtrA serine peptidase 4
|
|
HTT
|
huntingtin
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDS
|
iduronate 2-sulfatase
|
|
IFI30
|
interferon, gamma-inducible protein 30
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNE
|
interferon, epsilon
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGHMBP2
|
immunoglobulin mu binding protein 2
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL12B
|
interleukin 12B
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL33
|
interleukin 33
|
|
IL36RN
|
interleukin 36 receptor antagonist
|
|
IL37
|
interleukin 37
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
INHA
|
inhibin, alpha
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
INVS
|
inversin
|
|
IQCB1
|
IQ motif containing B1
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JAK2
|
Janus kinase 2
|
|
KCNC3
|
potassium channel, voltage gated Shaw related subfamily C, member 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA1462
|
KIAA1462
|
|
KIF1B
|
kinesin family member 1B
|
|
KIF5A
|
kinesin family member 5A
|
|
KIFC1
|
kinesin family member C1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KL
|
klotho
|
|
KLHL9
|
kelch-like family member 9
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KNG1
|
kininogen 1
|
|
KRT16
|
keratin 16, type I
|
|
KRT17
|
keratin 17, type I
|
|
KRT18
|
keratin 18, type I
|
|
KRT6B
|
keratin 6B, type II
|
|
LCN2
|
lipocalin 2
|
|
LDHA
|
lactate dehydrogenase A
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS13
|
lectin, galactoside-binding, soluble, 13
|
|
LGR4
|
leucine-rich repeat containing G protein-coupled receptor 4
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LINC-PINT
|
long intergenic non-protein coding RNA, p53 induced transcript
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LIPG
|
lipase, endothelial
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LOX
|
lysyl oxidase
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LPL
|
lipoprotein lipase
|
|
LRAT
|
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LYRM7
|
LYR motif containing 7
|
|
MAN1B1
|
mannosidase, alpha, class 1B, member 1
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
|
MATR3
|
matrin 3
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC3R
|
melanocortin 3 receptor
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCHR1
|
melanin-concentrating hormone receptor 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEFV
|
Mediterranean fever
|
|
MEGF10
|
multiple EGF-like-domains 10
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFF
|
mitochondrial fission factor
|
|
MFN2
|
mitofusin 2
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR126
|
microRNA 126
|
|
MIR134
|
microRNA 134
|
|
MIR137
|
microRNA 137
|
|
MIR146A
|
microRNA 146a
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR24-1
|
microRNA 24-1
|
|
MIR34A
|
microRNA 34a
|
|
MLH1
|
mutL homolog 1
|
|
MLLT11
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11
|
|
MMACHC
|
methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
|
MPG
|
N-methylpurine-DNA glycosylase
|
|
MPLKIP
|
M-phase specific PLK1 interacting protein
|
|
MPO
|
myeloperoxidase
|
|
MPZ
|
myelin protein zero
|
|
MRAP
|
melanocortin 2 receptor accessory protein
|
|
MSH2
|
mutS homolog 2
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MSX1
|
msh homeobox 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYBPH
|
myosin binding protein H
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYOT
|
myotilin
|
|
MYOZ2
|
myozenin 2
|
|
NAGK
|
N-acetylglucosamine kinase
|
|
NAGS
|
N-acetylglutamate synthase
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NDUFB11
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa
|
|
NDUFV2
|
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NEK6
|
NIMA-related kinase 6
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NHLRC1
|
NHL repeat containing E3 ubiquitin protein ligase 1
|
|
NINJ2
|
ninjurin 2
|
|
NLGN2
|
neuroligin 2
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH4
|
notch 4
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPY
|
neuropeptide Y
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NRG1
|
neuregulin 1
|
|
NRG3
|
neuregulin 3
|
|
NRP1
|
neuropilin 1
|
|
NTN1
|
netrin 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUCB2
|
nucleobindin 2
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPN4
|
opsin 4
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OXTR
|
oxytocin receptor
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PABPN1
|
poly(A) binding protein, nuclear 1
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PANK2
|
pantothenate kinase 2
|
|
PANX1
|
pannexin 1
|
|
PANX2
|
pannexin 2
|
|
PANX3
|
pannexin 3
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK3
|
Parkinson disease 3 (autosomal dominant, Lewy body)
|
|
PARK7
|
parkinson protein 7
|
|
PARL
|
presenilin associated, rhomboid-like
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX4
|
paired box 4
|
|
PCDH19
|
protocadherin 19
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PER3
|
period circadian clock 3
|
|
PF4
|
platelet factor 4
|
|
PFN1
|
profilin 1
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PITX3
|
paired-like homeodomain 3
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKP2
|
plakophilin 2
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLAC4
|
placenta-specific 4
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PML
|
promyelocytic leukemia
|
|
PNKP
|
polynucleotide kinase 3'-phosphatase
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLR3A
|
polymerase (RNA) III (DNA directed) polypeptide A, 155kDa
|
|
POLR3D
|
polymerase (RNA) III (DNA directed) polypeptide D, 44kDa
|
|
POMT1
|
protein-O-mannosyltransferase 1
|
|
PON1
|
paraoxonase 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKD2
|
protein kinase D2
|
|
PRMT3
|
protein arginine methyltransferase 3
|
|
PRNP
|
prion protein
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROK1
|
prokineticin 1
|
|
PROP1
|
PROP paired-like homeobox 1
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSENEN
|
presenilin enhancer gamma secretase subunit
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PSMD14
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 14
|
|
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)
|
|
PSORS1C2
|
psoriasis susceptibility 1 candidate 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RAPSN
|
receptor-associated protein of the synapse
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RBL1
|
retinoblastoma-like 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
|
RET
|
ret proto-oncogene
|
|
RHBDF2
|
rhomboid 5 homolog 2 (Drosophila)
|
|
RLS4
|
Restless legs syndrome 4
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNF213
|
ring finger protein 213
|
|
RPA2
|
replication protein A2, 32kDa
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RTN1
|
reticulon 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
RYR3
|
ryanodine receptor 3
|
|
S100A12
|
S100 calcium binding protein A12
|
|
SACS
|
sacsin molecular chaperone
|
|
SARM1
|
sterile alpha and TIR motif containing 1
|
|
SASS6
|
spindle assembly 6 homolog (C. elegans)
|
|
SBF2
|
SET binding factor 2
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCG5
|
secretogranin V
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN3A
|
sodium channel, voltage gated, type III alpha subunit
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SDCCAG8
|
serologically defined colon cancer antigen 8
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SELL
|
selectin L
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SETX
|
senataxin
|
|
SFTPA1
|
surfactant protein A1
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SGCG
|
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
|
|
SGOL1
|
shugoshin-like 1 (S. pombe)
|
|
SH3KBP1
|
SH3-domain kinase binding protein 1
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SHOX2
|
short stature homeobox 2
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIRT1
|
sirtuin 1
|
|
SIRT3
|
sirtuin 3
|
|
SIRT4
|
sirtuin 4
|
|
SKP1
|
S-phase kinase-associated protein 1
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC22A6
|
solute carrier family 22 (organic anion transporter), member 6
|
|
SLC22A8
|
solute carrier family 22 (organic anion transporter), member 8
|
|
SLC25A13
|
solute carrier family 25 (aspartate/glutamate carrier), member 13
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A14
|
solute carrier family 2 (facilitated glucose transporter), member 14
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC30A1
|
solute carrier family 30 (zinc transporter), member 1
|
|
SLC30A4
|
solute carrier family 30 (zinc transporter), member 4
|
|
SLC30A6
|
solute carrier family 30 (zinc transporter), member 6
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC52A1
|
solute carrier family 52 (riboflavin transporter), member 1
|
|
SLC52A2
|
solute carrier family 52 (riboflavin transporter), member 2
|
|
SLC52A3
|
solute carrier family 52 (riboflavin transporter), member 3
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCAL1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNRNP200
|
small nuclear ribonucleoprotein 200kDa (U5)
|
|
SNRNP70
|
small nuclear ribonucleoprotein 70kDa (U1)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORCS1
|
sortilin-related VPS10 domain containing receptor 1
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SPAST
|
spastin
|
|
SPATA7
|
spermatogenesis associated 7
|
|
SPG7
|
spastic paraplegia 7 (pure and complicated autosomal recessive)
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPINK5
|
serine peptidase inhibitor, Kazal type 5
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPR
|
sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)
|
|
SPRTN
|
SprT-like N-terminal domain
|
|
SQSTM1
|
sequestosome 1
|
|
ST8SIA1
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STH
|
saitohin
|
|
STIM1
|
stromal interaction molecule 1
|
|
STOX1
|
storkhead box 1
|
|
STX1A
|
syntaxin 1A (brain)
|
|
STXBP1
|
syntaxin binding protein 1
|
|
SULF1
|
sulfatase 1
|
|
TAC3
|
tachykinin 3
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBP
|
TATA box binding protein
|
|
TBX19
|
T-box 19
|
|
TCERG1
|
transcription elongation regulator 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCN2
|
transcobalamin II
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TF
|
transferrin
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGM2
|
transglutaminase 2
|
|
TH
|
tyrosine hydroxylase
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TKT
|
transketolase
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM173
|
transmembrane protein 173
|
|
TMEM70
|
transmembrane protein 70
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNNI2
|
troponin I type 2 (skeletal, fast)
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TRAPPC11
|
trafficking protein particle complex 11
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRIM24
|
tripartite motif containing 24
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRIM62
|
tripartite motif containing 62
|
|
TRMT10A
|
tRNA methyltransferase 10 homolog A (S. cerevisiae)
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSC22D3
|
TSC22 domain family, member 3
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TTC7A
|
tetratricopeptide repeat domain 7A
|
|
TTK
|
TTK protein kinase
|
|
TTN
|
titin
|
|
TTR
|
transthyretin
|
|
UBQLN1
|
ubiquilin 1
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
|
UMOD
|
uromodulin
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
UNC93B1
|
unc-93 homolog B1 (C. elegans)
|
|
USH1C
|
Usher syndrome 1C (autosomal recessive, severe)
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VWF
|
von Willebrand factor
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNT16
|
wingless-type MMTV integration site family, member 16
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT5B
|
wingless-type MMTV integration site family, member 5B
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
ZMPSTE24
|
zinc metallopeptidase STE24
|
|
ZNF366
|
zinc finger protein 366
|